Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach

International Journal of Mycobacteriology

Volumn 5, Issue 1, 2016, Pages 34-43

  Pandey, Kirti ^a   Sharma, Monika ^a   Saarav, Iti ^a   Singh, Swati ^a   Dutta, Prasun ^b   Bhardwaj, Anshu ^b   Sharma, Sadhna ^a  

^a UNIVERSITY OF DELHI   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

CD8+ T cell epitopes; Cellular immunity; DosR operon; Mycobacterium tuberculosis; TB vaccines

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 1; MYCOBACTERIUM TUBERCULOSIS VACCINE; MYCOBACTERIUM VACCINE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BCG VACCINE; DOSR PROTEIN, MYCOBACTERIUM TUBERCULOSIS; PEPTIDE; PROTEIN BINDING; PROTEIN KINASE;

ALLELE; AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; BINDING AFFINITY; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSR REGULON GENE; GENE; MOLECULAR DOCKING; OPERON; PREDICTION; PRIORITY JOURNAL; REVERSE VACCINOLOGY; SCORING SYSTEM; VACCINATION; VAXIJEN SCORE; CD8+ T LYMPHOCYTE; COMPUTER SIMULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; REGULON;

ALLELES; BACTERIAL PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; COMPUTER SIMULATION; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; PROTEIN BINDING; PROTEIN KINASES; REGULON; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS VACCINES;

EID: 84959097981     PISSN: 22125531     EISSN: 2212554X     Source Type: Journal    
DOI: 10.1016/j.ijmyco.2015.10.005     Document Type: Article

References (41)

1. Kruh N.A., Troudt J., Izzo A., et al. Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS One 2010, 5:e13938.
2. Raja A. Immunology of tuberculosis. Indian J. Med. Res. 2004, 120:213-232.
3. Singh S., Saraav I., Sharma S. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis. Vaccine 2014, 32:712-716.
4. Chaitra M.G., Shaila M.S., Nayak R. Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis. J. Med. Microbiol. 2008, 57:1079-1086.
5. Axelsson-Robertson R., Weichold F., Sizemore D., et al. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses. Immunology 2009, 129:496-505.
6. Axelsson-Robertson R., Magalhaes I., Parida S.K., et al. The immunological footprint of Mycobacterium tuberculosis T-cell epitope recognition. J. Infect. Dis. 2012, 205(Suppl. 2):S301-315.
7. Schuck S.D., Mueller H., Kunitz F., et al. Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS One 2009, 4:e5590.
8. Gideon H.P., Wilkinson K.A., Rustad T.R., et al. Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell response. J. Immunol. 2012, 189:5867-5876.
9. Gideon H.P., Wilkinson K.A., Rustad T.R., et al. Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines. PLoS Pathog. 2013, 6:e1001237.
10. Serra-Vidal M.M., Latorre I., Franken K.L., et al. Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis. Front. Microbiol. 2014, 5:517.
11. Vani J., Shaila M.S., Chandra N.R., et al. A combined immuno-informatics and structure-based modeling approach for prediction of T cell epitopes of secretory proteins of Mycobacterium tuberculosis. Microbes Infect. 2006, 8:738-746.
12. Rozot V., Vigano S., Mazza-Stalder J., et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur. J. Immunol. 2013, 43:1568-1577.
13. Caccamo N., Guggino G., Meraviglia S., et al. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS One 2009, 4:e5528.
14. Lewinsohn D.A., Winata E., Swarbrick G.M., et al. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog. 2007, 3:1240-1249.
15. Chaitra M.G., Hariharaputran S., Chandra N.R., Shaila M.S., Nayak R. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential. Vaccine 2005, 23:1265-1272.
16. TubercuList, available at: .
17. Yu N.Y., Wagner J.R., Laird M.R., et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 2010, 26:1608-1615.
18. Tusnady G.E., Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics 2001, 17:849-850.
19. Krogh A., Larsson B., von Heijne G., et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001, 305:567-580.
20. Petersen T.N., Brunak S., von Heijne G., et al. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 2011, 8:785-786.
21. Parker K.C., Bednarek M.A., Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 1994, 152:163-175.
22. BIMAS, available at: .
23. Nielsen M., Lundegaard C., Worning P., et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 2003, 12:1007-1017.
24. Nielsen M., Lundegaard C., Worning P., et al. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 2004, 20:1388-1397.
25. Lundegaard C., Lund O., Nielsen M. Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10, and 11 using prediction tools trained on 9mers. Bioinformatics 2008, 24:1397-1398.
26. Doytchinova I.A., Flower D.R. VaxiJen: a server for prediction of protective antigens, tumor antigens and subunit vaccines. BMC Bioinf. 2007, 8:4.
27. M. Kurcinski, M. Jamroz, M. Blaszczyk, et al., CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site, Nucleic Acids Res. In press. http://doi.dx.org/10.1093/nar/gkv456.
28. Macindoe G., Mavridis L., Venkatraman V., et al. Hex Server: an FFT-based protein docking server powered by graphics processors. Nucleic Acids Res. 2010, 38:W445-449.
29. Andersen P. Vaccine strategies against latent tuberculosis infection. Trends Microbiol. 2007, 15:7-13.
30. Cho S., Mehra V., Thoma-Uszynski S., et al. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc. Natl. Acad. Sci. USA 2000, 97:12210-12215.
31. Bihl F., Frahm N., Di Giammarino L., et al. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 2006, 176:4094-4101.
32. Weichold F.F., Mueller S., Kortsik C., et al. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun. 2007, 8:334-343.
33. Webb A.I., Dunstone M.A., Chen W., et al. Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. J. Biol. Chem. 2004, 279:23438-23446.
34. Global tuberculosis report, available at: .
35. Middleton D., Menchaca L., Rood H., et al. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 2003, 61:403-407.
36. Chaitra M.G., Shaila M.S., Chandra N.R., et al. HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis. Scand. J. Immunol. 2008, 67:411-417.
37. Balamurugan A., Sharma S.K., Mehra N.K. Human leukocyte antigen class I supertypes influence susceptibility and severity of tuberculosis. J. Infect. Dis. 2004, 189:805-811.
38. Mehra N.K., Kaur G. MHC-based vaccination approaches: progress and perspectives. Expert Rev. Mol. Med. 2003, 5:1-17.
39. Yim J.J., Selvaraj P. Genetic susceptibility in tuberculosis. Respirology 2010, 15:241-256.
40. Rammensee H.G., Falk K., Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 1993, 11:213-244.
41. Fan Q.R., Wiley D.C. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J. Exp. Med. 1999, 190:113-123.